Scholars Central

Research articlePublished 2013

Soluble Receptor for Advanced Glycation End-products Levels in Chronic Heart Failure and Its Correlation to Left Ventricular Ejection Function

Authors: Colomba Falcone, Sara Bozzini, Angela D’Angelo, Maria Paola Buzzi, Rossana Totaro, Rossana Falcone, Gabriele Pelissero

Clinical and Experimental Cardiology

Volume 4 · Issue 10 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The Receptor for Advanced Glycation End-products (RAGE), a multi-ligand member of the immunoglobulin superfamily, is a ubiquitous receptor present on epithelial, neuronal, vascular and inflammatory cells. AGEs have been implicated in vascular and myocardial dysfunction and in development of atherosclerosis but little are known about the role of the AGE-RAGE system in heart failure. The main objective of the study was to assess sRAGE plasma levels in patients with Chronic Heart Failure (CHF) focusing on patients with severe reduction of left ventricle function. We measured sRAGE plasma levels in 389 patients with CHF and 319 stable patients with Coronary Artery Disease (CAD). Patients with CHF had significantly lower values of soluble RAGE in respect to stable CAD population. The linear regression analysis showed that LVEF (Left Ventricularv Ejection Fraction) significantly correlated with sRAGE plasma concentrations; sRAGE plasma levels were significantly lower in patients with severe left ventricular systolic dysfunction compared with those with ejection Fraction ≥ 30%. Our data support a positive correlation between soluble RAGE plasma levels and left ventricular ejection fraction in the CHF population; we demonstrated that in subjects with CHF and severe left ventricular systolic dysfunction, soluble RAGE plasma concentrations were significantly lower in comparison with patients with moderate left ventricular dysfunction. This study suggests the possibility that soluble RAGE can be considered a new element to be used in prognostic stratification in patients affected by CHF.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical and Experimental Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Colomba Falcone”
  • BylineArticles whose byline prints “Sara Bozzini”
  • BylineArticles whose byline prints “Angela D’Angelo”
  • BylineArticles whose byline prints “Maria Paola Buzzi”
  • BylineArticles whose byline prints “Rossana Totaro”
  • BylineArticles whose byline prints “Rossana Falcone”
  • BylineArticles whose byline prints “Gabriele Pelissero”